Back
Unity Biotechnology 10K Form
Sell
24
UBX
Unity Biotechnology
Last Price:
1.16
Seasonality Move:
12.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive UBX News And Ratings
See the #1 stock for the next 7 days that we like better than UBX
UBX Financial Statistics
Sales & Book Value
| Annual Sales: | $236K |
|---|---|
| Cash Flow: | $-5.19M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.84 |
| Price / Book: | 1.42 |
Profitability
| EPS (TTM): | -1.27000 |
|---|---|
| Net Income (TTM): | $-21.89M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Unity Biotechnology Earnings Forecast
Key Unity Biotechnology Financial Ratios
- The Interest Expense is -6.15% of Operating Income.
- Per Share Earnings over the last 8 years have been positive in 6 years.
Unity Biotechnology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | UBX |
| CUSIP: | 91381U |
| Website: | unitybiotechnology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
UBX Technical Analysis vs Fundamental Analysis
Sell
24
Unity Biotechnology (UBX)
is a Sell
Is Unity Biotechnology a Buy or a Sell?
-
Unity Biotechnology stock is rated a Sell
The current Unity Biotechnology [UBX] share price is $1.17. The Score for UBX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.